Hiroyuki Hino - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Hiroyuki Hino

Showing results (21-30 of 26) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 26 results.

Cancer Reports (Hoboken, N.J.)|November 24, 2021

Complete and durable response of pulmonary large-cell neuroendocrine carcinoma to pembrolizumabNaoki Kadota, Nobuo Hatakeyama, Hiroyuki Hino, et al.

Internal Medicine (Tokyo, Japan)|July 16, 2011

Immunoglobulin D-lambda type multiple myeloma presenting with FDG-PET/CT negative bone marrow involvementHisanori Machida, Tsutomu Shinohara, Hiroyuki Hino, et al.

Thoracic Cancer|December 21, 2021

Dramatic response to immunochemotherapy followed by salvage surgery in an elderly lung cancer patientYoshio Okano, Michihiro Kunishige, Yoshihiro Kondo, et al.

Cancer Reports (Hoboken, N.J.)|July 7, 2025

First-Line Osimertinib for EGFR-Mutated Squamous Cell Lung Carcinoma: A Case ReportYugo Matsumura, Seiya Ichihara, Kaori Nii, et al.

Thoracic Cancer|December 17, 2024

Pathological Complete Response to a Single Dose of Pembrolizumab-Based Chemoimmunotherapy for Squamous Cell Carcinoma of the Lung: A Case ReportYugo Matsumura, Seiya Ichihara, Kaori Nii, et al.

Journal of the Neurological Sciences|July 18, 2016

A family with hereditary diffuse leukoencephalopathy with spheroids caused by a novel c.2442+2T>C mutation in the CSF1R geneIto Kawakami, Eizo Iseki, Koji Kasanuki, et al.

Pageof 3

Search research articles

Showing results (21-30 of 26) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 26 results.

Cancer Reports (Hoboken, N.J.)|November 24, 2021

Complete and durable response of pulmonary large-cell neuroendocrine carcinoma to pembrolizumabNaoki Kadota, Nobuo Hatakeyama, Hiroyuki Hino, et al.

Internal Medicine (Tokyo, Japan)|July 16, 2011

Immunoglobulin D-lambda type multiple myeloma presenting with FDG-PET/CT negative bone marrow involvementHisanori Machida, Tsutomu Shinohara, Hiroyuki Hino, et al.

Thoracic Cancer|December 21, 2021

Dramatic response to immunochemotherapy followed by salvage surgery in an elderly lung cancer patientYoshio Okano, Michihiro Kunishige, Yoshihiro Kondo, et al.

Cancer Reports (Hoboken, N.J.)|July 7, 2025

First-Line Osimertinib for EGFR-Mutated Squamous Cell Lung Carcinoma: A Case ReportYugo Matsumura, Seiya Ichihara, Kaori Nii, et al.

Thoracic Cancer|December 17, 2024

Pathological Complete Response to a Single Dose of Pembrolizumab-Based Chemoimmunotherapy for Squamous Cell Carcinoma of the Lung: A Case ReportYugo Matsumura, Seiya Ichihara, Kaori Nii, et al.

Journal of the Neurological Sciences|July 18, 2016

A family with hereditary diffuse leukoencephalopathy with spheroids caused by a novel c.2442+2T>C mutation in the CSF1R geneIto Kawakami, Eizo Iseki, Koji Kasanuki, et al.

Pageof 3